These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention of meningococcal disease by group C polysaccharide vaccine. Artenstein MS; Gold R; Zimmerly JG; Wyle FA; Schneider H; Harkins C N Engl J Med; 1970 Feb; 282(8):417-20. PubMed ID: 4983754 [No Abstract] [Full Text] [Related]
5. Present status of polysaccharide vaccines in the prevention of meningococcal disease. Gold R; Lepow ML Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651 [No Abstract] [Full Text] [Related]
7. [Immunoprophylaxis of meningococcal infection among the troops]. Khokhlov DT; Efimov EI Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904 [No Abstract] [Full Text] [Related]
8. Commentary: prophylaxis for contacts of patients with meningococcal disease. Gold R Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315 [No Abstract] [Full Text] [Related]
9. Vaccine research: new vaccines and evidence of vaccine safety. Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064 [No Abstract] [Full Text] [Related]
10. [Why and when to vaccinate against meningococcal disease]. Humble M Nord Med; 1984; 99(10):248-50, 253. PubMed ID: 6436785 [No Abstract] [Full Text] [Related]
11. Change in recommendation for meningococcal vaccine for travelers. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(5):104. PubMed ID: 10084899 [No Abstract] [Full Text] [Related]
12. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease. Frøholm LO NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045 [No Abstract] [Full Text] [Related]
13. Meningococcal vaccine. Med Lett Drugs Ther; 1974 Aug; 16(18):74-5. PubMed ID: 4212159 [No Abstract] [Full Text] [Related]
14. [The prevention of meningococcal infection at the present day]. Deviatkina NP Feldsher Akush; 1990 Apr; 55(4):20-2. PubMed ID: 2116327 [No Abstract] [Full Text] [Related]
15. Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine. Bremner C; Lennon D; Martin D; Baker M; Rümke H N Z Med J; 1999 Jul; 112(1091):257-9. PubMed ID: 10448985 [No Abstract] [Full Text] [Related]
16. The immunological responses observed in field studies in Africa with group A meningococcal vaccines. Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975 [No Abstract] [Full Text] [Related]
17. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239 [TBL] [Abstract][Full Text] [Related]
18. Further conquest of the meningococcus. Lepow ML; Gold R N Engl J Med; 1977 Sep; 297(13):721-2. PubMed ID: 408684 [No Abstract] [Full Text] [Related]
19. Vaccination against meningococcal disease. Griffiss JM N Engl J Med; 1983 Jun; 308(23):1421. PubMed ID: 6405276 [No Abstract] [Full Text] [Related]
20. [Experience with the immunoprophylaxis of meningococcal infection in military collectives]. Efimov EI Voen Med Zh; 1989 Apr; (4):49. PubMed ID: 2503934 [No Abstract] [Full Text] [Related] [Next] [New Search]